STOCK TITAN

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

NovaBay Pharmaceuticals (NYSE American: NBY) has announced its upcoming second quarter 2024 financial results conference call, scheduled for August 13, 2024, after market close. The call will begin at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). Investors can pre-register for the call or dial in directly. A live webcast will be available on the company's website, and a replay will be accessible until September 3, 2024. This event provides an opportunity for investors to gain insights into NovaBay's financial performance and future outlook.

NovaBay Pharmaceuticals (NYSE American: NBY) ha annunciato la sua prossima teleconferenza sui risultati finanziari del secondo trimestre 2024, prevista per il 13 agosto 2024, dopo la chiusura del mercato. La chiamata avrà inizio alle 16:30 ora orientale (13:30 ora pacifica). Gli investitori possono registrarsi in anticipo per la chiamata o chiamare direttamente. Una web conference in diretta sarà disponibile sul sito web dell'azienda e una registrazione sarà accessibile fino al 3 settembre 2024. Questo evento offre un'opportunità agli investitori per ottenere informazioni sulle performance finanziarie di NovaBay e sulle prospettive future.

NovaBay Pharmaceuticals (NYSE American: NBY) ha anunciado su próxima conferencia telefónica sobre los resultados financieros del segundo trimestre de 2024, programada para el 13 de agosto de 2024, después del cierre del mercado. La llamada comenzará a las 4:30 p.m. hora del este (1:30 p.m. hora del pacífico). Los inversionistas pueden preregistrarse para la llamada o marcar directamente. Habrá una transmisión web en vivo disponible en el sitio web de la compañía, y una grabación estará accesible hasta el 3 de septiembre de 2024. Este evento proporciona una oportunidad para que los inversionistas obtengan información sobre el rendimiento financiero de NovaBay y sus perspectivas futuras.

노바베이 제약(NYSE American: NBY)이 2024년 2분기 재무 결과 발표를 위한 콘퍼런스 콜이 2024년 8월 13일 시장 마감 후 진행될 것이라고 발표했습니다. 통화는 동부 표준시 오후 4시 30분 (태평양 표준시 오후 1시 30분)에 시작됩니다. 투자자는 사전 등록을 하거나 직접 전화에 참여할 수 있습니다. 회사 웹사이트에서 생중계가 제공되며, 녹화된 회의는 2024년 9월 3일까지 이용 가능합니다. 이 행사는 투자자들에게 노바베이의 재무 성과 및 미래 전망에 대한 통찰을 얻을 수 있는 기회를 제공합니다.

NovaBay Pharmaceuticals (NYSE American: NBY) a annoncé sa prochaine conférence téléphonique sur les résultats financiers du deuxième trimestre 2024, prévue pour le 13 août 2024, après la fermeture du marché. L'appel commencera à 16h30, heure de l'Est (13h30, heure du Pacifique). Les investisseurs peuvent se préinscrire pour l'appel ou composer directement le numéro. Un webinaire en direct sera disponible sur le site Web de l'entreprise, et une rediffusion sera accessible jusqu'au 3 septembre 2024. Cet événement offre une opportunité aux investisseurs d'obtenir des informations sur la performance financière de NovaBay et ses perspectives futures.

NovaBay Pharmaceuticals (NYSE American: NBY) hat seine bevorstehende Telefonkonferenz zu den finanziellen Ergebnissen des zweiten Quartals 2024 angekündigt, die für den 13. August 2024 nach Börsenschluss geplant ist. Die Konferenz beginnt um 16:30 Uhr Eastern Time (13:30 Uhr Pazifische Zeit). Investoren können sich im Voraus für die Konferenz registrieren oder direkt anrufen. Ein Live-Webcast wird auf der Unternehmenswebsite verfügbar sein, und eine Aufzeichnung wird bis zum 3. September 2024 zugänglich sein. Diese Veranstaltung bietet den Investoren eine Gelegenheit, Einblicke in die finanzielle Leistung von NovaBay und die zukünftigen Aussichten zu erhalten.

Positive
  • None.
Negative
  • None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:

Tuesday, August 13, 4:30 p.m. ET / 1:30 p.m. PT

 

Pre-Registration:

Participants can pre-register for the conference call here:

 

Callers who pre-register will be emailed conference details and unique Registration ID to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

 

Dial In:

Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:

833-816-1121 from within the U.S.

412-317-1862 from outside the U.S.

The live webcast of the conference call also will be available on the Events section of the Company website. A replay of the call will be available beginning two hours after its completion through September 3, 2024 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 3413491. The webcast will also be archived here.

About NovaBay Pharmaceuticals, Inc:

NovaBay's leading product Avenova® Antimicrobial Lid & Lash Solution is often recommended by eyecare professionals for blepharitis and dry eye disease. Manufactured in the U.S., Avenova spray is formulated with NovaBay's patented, proprietary, stable and pure form of hypochlorous acid. All Avenova products are available directly to consumers through online distribution channels such as Amazon.com and Avenova.com.

Socialize and Stay Informed on NovaBays Progress
Like us on Facebook
Follow us on X
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc.

FAQ

When will NovaBay Pharmaceuticals (NBY) release its Q2 2024 financial results?

NovaBay Pharmaceuticals (NBY) will release its Q2 2024 financial results on Tuesday, August 13, 2024, after market close.

What time is NovaBay's (NBY) Q2 2024 earnings conference call?

NovaBay's (NBY) Q2 2024 earnings conference call is scheduled for Tuesday, August 13, 2024, at 4:30 p.m. Eastern time / 1:30 p.m. Pacific time.

How can investors participate in NovaBay's (NBY) Q2 2024 earnings call?

Investors can participate in NovaBay's (NBY) Q2 2024 earnings call by pre-registering online or dialing in directly. U.S. callers can dial 833-816-1121, while international callers should use 412-317-1862.

Will there be a replay available for NovaBay's (NBY) Q2 2024 earnings call?

Yes, a replay of NovaBay's (NBY) Q2 2024 earnings call will be available until September 3, 2024. It can be accessed by dialing 877-344-7529 (U.S.), 855-669-9658 (Canada), or 412-317-0088 (international) and entering conference ID 3413491.

NovaBay Pharmaceuticals, Inc.

NYSE:NBY

NBY Rankings

NBY Latest News

NBY Stock Data

2.32M
4.89M
0.01%
0.24%
1.14%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
EMERYVILLE